Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Retained Earnings: 2011-2024

Historic Retained Earnings for Mimedx Group (MDXG) over the last 14 years, with Dec 2024 value amounting to -$91.3 million.

  • Mimedx Group's Retained Earnings rose 41.36% to -$57.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$57.9 million, marking a year-over-year increase of 41.36%. This contributed to the annual value of -$91.3 million for FY2024, which is 31.73% up from last year.
  • As of FY2024, Mimedx Group's Retained Earnings stood at -$91.3 million, which was up 31.73% from -$133.7 million recorded in FY2023.
  • In the past 5 years, Mimedx Group's Retained Earnings registered a high of -$91.3 million during FY2024, and its lowest value of -$191.9 million during FY2022.
  • Its 3-year average for Retained Earnings is -$138.9 million, with a median of -$133.7 million in 2023.
  • Per our database at Business Quant, Mimedx Group's Retained Earnings tumbled by 48.25% in 2020 and then surged by 31.73% in 2024.
  • Mimedx Group's Retained Earnings (Yearly) stood at -$151.4 million in 2020, then fell by 6.79% to -$161.7 million in 2021, then declined by 18.67% to -$191.9 million in 2022, then spiked by 30.34% to -$133.7 million in 2023, then spiked by 31.73% to -$91.3 million in 2024.